Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilization. Vick EJ, Hassan A, Choi K, Bennett J, et al. Leukemia 2025;39:2163-2173.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Vick EJ, Hassan A, Choi K, Bennett J, et al. Targeting of IRAK4 and GSPT1 enhances therapeutic efficacy in AML via c-Myc destabilization. Leukemia 2025;39:2163-2173.
PMID: 40670672